Bristol-Myers Squibb Company
Compounds useful as immunomodulators

Last updated:

Abstract:

The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

Status:
Grant
Type:

Utility

Filling date:

11 Oct 2016

Issue date:

18 Aug 2020